reviewTop 10% cited
Drug repositioning: identifying and developing new uses for existing drugs
Nature Reviews Drug Discovery · 2004 · Vol. 3(8) · pp. 673–683
Ted T. Ashburn✉(Dynavax Technologies (Germany))Karl B. Thor
Pharmacogenetics and Drug MetabolismCancer Treatment and PharmacologyStatistical Methods in Clinical TrialsBiopharmaceuticalDrug repositioningBusinessProductivityDrug discoveryDrugPharmacopoeiaDrug industryPharmaceutical industryBiotechnology
MeSH terms
HumansPharmacokineticsTechnology, PharmaceuticalTherapeutic EquivalencyDrug DesignDrug Delivery Systems
Funding
- Eli Lilly and Company
Citations
3,198
FWCI
9.05
field-weighted impact
References
17
Percentile
98%
vs. same field & year
Citations per year
Cited by
Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
Science Translational Medicine · 2011 · 827 citations
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Antimicrobial Agents and Chemotherapy · 2020 · 709 citations
Drug repurposing: progress, challenges and recommendations
Nature Reviews Drug Discovery · 2018 · 4,479 citations
Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
PLoS Computational Biology · 2012 · 834 citations
Multi-target pharmacology: possibilities and limitations of the “skeleton key approach” from a medicinal chemist perspective
Frontiers in Pharmacology · 2015 · 362 citations
Combination therapy in combating cancer
Oncotarget · 2017 · 2,440 citations
Systematic integration of biomedical knowledge prioritizes drugs for repurposing
eLife · 2017 · 579 citations
References
Sexual Dysfunction in the United States
JAMA · 1999 · 5,088 citations
The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction
Urology · 1997 · 5,770 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.